«Olive oil makes you live longer» is one of the most shared nutrition messages there is. It rests on real, large, carefully conducted studies – and it still claims more than those studies show. This article takes the numbers exactly as the journals published them: effect sizes, confidence intervals, and the question of which part of the evidence comes from an experiment and which part only from observation.
What «life expectancy» actually means in these studies
None of the work discussed here measures years of life. It measures the risk of dying during the follow-up period and expresses it as a hazard ratio (HR) or relative risk (RR). An HR of 0.81 means that in the higher-intake group, death occurred 19 per cent less often per unit of time. That is not the same as «19 per cent longer life»; how many years that would amount to was never calculated. Any figure in years that turns up in a consumer guide is a model, not a measurement. The confidence interval (CI) matters just as much: if it includes 1.0, the difference is not statistically secure. That is where the whole story turns below.
The cohort studies: three meta-analyses, one consistent picture
Observational studies follow people who decide for themselves how much olive oil they eat. Three research groups have pooled such cohorts independently, and their results land remarkably close together.
| Meta-analysis | Evidence base | All-cause mortality |
|---|---|---|
| Xia et al., Frontiers in Nutrition 2022 | 11 cohorts, about 713,000 people, 173,817 deaths | RR 0.83 (95% CI 0.77–0.90) |
| Martínez-González et al., Clinical Nutrition 2022 | 733,420 people, 174,081 deaths | RR 0.89 (95% CI 0.85–0.93) per additional 25 g/day |
| Del Saz-Lara et al., Food & Function 2024 | 7 studies in the meta-analysis | HR 0.85 (95% CI 0.80–0.91) |
Depending on the analysis, then, all-cause mortality is 11 to 17 per cent lower, with tight intervals that clearly exclude 1.0. One divergence is worth noting: the Navarre analysis found no association with cancer incidence (RR 0.94, 95% CI 0.86–1.03), while the 2024 paper found lower cancer mortality (HR 0.89, 95% CI 0.86–0.93). Falling ill and dying of the illness are different endpoints – a detail headlines routinely lose.
The largest single study: 92,383 people over 28 years
The most cited single paper appeared in 2022 in the Journal of the American College of Cardiology. A team led by Marta Guasch-Ferré followed 60,582 women and 31,801 men from 1990 to 2018; 36,856 of them died. People consuming more than 7 grams of olive oil a day (a good half tablespoon) were compared with those who never or rarely used it.
| Endpoint | Hazard ratio (95% CI) |
|---|---|
| Death from any cause | 0.81 (0.78–0.84) |
| Cardiovascular disease | 0.81 (0.75–0.87) |
| Cancer | 0.83 (0.78–0.89) |
| Neurodegenerative disease | 0.71 (0.64–0.78) |
| Respiratory disease | 0.82 (0.72–0.93) |
The study also modelled what happens when 10 grams a day of another fat is replaced by olive oil: instead of butter HR 0.86 (0.83–0.88), instead of margarine 0.87 (0.85–0.89), instead of dairy fat 0.87 (0.84–0.89), instead of mayonnaise 0.81 (0.78–0.84). Against other vegetable oils combined, no significant association was found. The advantage lies in replacing animal and heavily processed fats, not in olive oil as such. What that means day to day is in our practical guide to daily olive oil.
The dose: nothing more happens above 20 grams a day
The Frontiers in Nutrition analysis also calculated the dose-response relationship: per additional 5 grams of olive oil a day, an RR of 0.96 (95% CI 0.95–0.96) for all-cause mortality. The shape is explicitly non-linear – beyond roughly 20 grams a day the authors found little or no further reduction in risk. Spooning down more buys nothing statistically, only calories.
The one randomised trial – and its awkward result
Observation cannot separate cause from effect. That needs an experiment, and there is exactly one on this scale: the Spanish PREDIMED trial. 7,447 people aged 55 to 80 at high cardiovascular risk were assigned to one of three diets – a Mediterranean diet with extra virgin olive oil, a Mediterranean diet with nuts, or a reduced-fat control diet. The olive oil group received 1 litre of oil per household per week, with a target of at least 4 tablespoons (about 50 grams) per person per day, several times the 7 grams of the cohort studies. Median follow-up was 4.8 years. The trial was published in 2013, withdrawn over flaws in the allocation, and republished in 2018 in the New England Journal of Medicine with a corrected analysis.
| Endpoint (olive oil group vs control) | Hazard ratio (95% CI) |
|---|---|
| Primary endpoint: myocardial infarction, stroke or cardiovascular death | 0.69 (0.53–0.91) |
| Stroke | 0.65 (0.44–0.95) |
| Myocardial infarction | 0.82 (0.52–1.30) |
| Death from cardiovascular causes | 0.62 (0.36–1.06) |
| Death from any cause | 0.90 (0.69–1.18) |
This is the part the consumer guides leave out. The experiment confirms the cardiovascular effect impressively, and the stroke result with it. On all-cause mortality it showed no secure difference: 118, 116 and 114 deaths across the three groups, and a confidence interval that includes 1.0. For both Mediterranean groups combined the HR was 0.98 (0.77–1.24). The sentence «olive oil extends life» has not been confirmed by the only randomised trial on the question.
Why observation and experiment diverge
- Statistical power: PREDIMED ran for a median of 4.8 years and counted roughly 350 deaths in total. The Harvard cohorts counted 36,856 over 28 years. A 10 per cent difference is barely detectable with 350 cases and easy with 36,856.
- Residual confounding: people who use olive oil smoke less, move more, eat more vegetables and often earn more. Cohort studies adjust for that, never completely. The JACC authors say so themselves.
- A pattern was tested, not an oil: PREDIMED compared a whole Mediterranean diet with a reduced-fat one, so the effect cannot be attributed to the oil alone. And intake in the cohorts was captured by food frequency questionnaire – the best tool available and still imprecise.
The fair conclusion is this: the evidence for the heart and the arteries is strong and partly experimental. The evidence for a longer life overall is purely observational – consistent, but not causally established. The compounds suspected of doing the work are covered in polyphenols and antioxidants in olive oil; the view across whole countries rather than individuals is in our comparison of consumption and life expectancy by country.
What follows for everyday life in Switzerland
The Swiss dietary recommendations of 2024 state, for oils and fats, 2 tablespoons of vegetable oil a day (20 grams), of which at least 1 tablespoon should be rapeseed oil, with butter, margarine and other fats used sparingly (a maximum of 10 grams a day). That fits the evidence remarkably well: the second tablespoon may be olive oil, and the largest measured gain arises precisely where that oil replaces butter, cream or a ready-made dressing – not where it is added on top. For athletes, the Swiss food pyramid sets its own portions; see Olive oil in sports nutrition.
For shopping that means: extra virgin grade, a recent harvest year, a dark bottle. Our overview of olive oil prices in Switzerland puts prices per litre and test verdicts side by side. Spending more extends no life – but an oil you enjoy, and therefore actually use instead of butter, changes your fat balance immediately.
Frequently asked questions
Is it proven that olive oil extends life?
No. Observational studies show death rates 11 to 19 per cent lower at higher intakes. The only randomised trial, PREDIMED, found no secure difference in all-cause mortality (HR 0.90, 95% CI 0.69–1.18), though it did find markedly fewer heart attacks and strokes.
How many years are we talking about?
None of these studies measured that. They report risk per unit of time, not years of life. Figures such as «x years longer» come from models, not from the data.
How much olive oil a day makes sense?
In the cohorts a difference appeared from a good half tablespoon (over 7 grams) a day. Above roughly 20 grams a day the curve flattens. The Swiss recommendation for vegetable oils overall is 2 tablespoons (20 grams) daily, at least one of them rapeseed oil.
Is olive oil superior to other vegetable oils?
Not in the largest analysis: against other vegetable oils combined, no significant difference was measurable. The advantage showed up against butter, margarine, dairy fat and mayonnaise.
Why do the cohort studies and the trial disagree?
Because they do different jobs. The cohorts have decades and tens of thousands of deaths, and therefore the precision to see small differences – but no random allocation. PREDIMED has the allocation but ran for barely five years with about 350 deaths.
Sources
- Guasch-Ferré M et al.: Consumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults. J Am Coll Cardiol 2022;79(2):101–112 (doi:10.1016/j.jacc.2021.10.041)
- Full text of the same paper in PubMed Central (PMC8851878)
- Xia M et al.: Olive oil consumption and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies. Front Nutr 2022;9:1041203
- Martínez-González MA et al.: Effect of olive oil consumption on cardiovascular disease, cancer, type 2 diabetes, and all-cause mortality. Clin Nutr 2022;41(12):2659–2682
- Del Saz-Lara A et al.: Association between olive oil consumption and all-cause, cardiovascular and cancer mortality in adult subjects. Food Funct 2024;15(23):11640–11649
- Estruch R et al.: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med 2018;378:e34
- Federal Food Safety and Veterinary Office: Swiss dietary recommendations for adults
- Swiss Society for Nutrition / FSVO: Swiss dietary recommendations, short version (PDF)
Note: This article is for general information only and does not replace advice from a doctor or dietitian. If you have health questions, please consult a professional.
